Immunophotonics Announces First Patient Treated in Clinical Study Evaluating IP-001 in Patients with Advanced Solid Tumors

NEXT STORY
NOHO PARTNERS INTERIM REPORT 1 JANUARY–30 SEPTEMBER 2020: Quick recovery of demand and profitability measures generated operating cash flow of MEUR 5.5 – restrictions weaken the outlook for the remainder of the year
PREV STORY
Press news Biocartis Group NV: Biocartis Announces CE-marking of its Fully Automated Idylla™ SARS-CoV-2 Test
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeiGene Announces Preliminary Results from the Phase 1 Clinical Trial of Zanubrutinib in Chinese Patients with B-Cell Lymphoma at Annual Meeting of the Chinese Society of Clinical Oncology

BEIJING, China and CAMBRIDGE, Mass., Sept. 21, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: ...

author_avatar
NASDAQ Market News

American Botanical Council Presents Botanical Excellence Awards at 16th Annual Celebration Ceremony

author_avatar
NASDAQ Market News

CorMedix Inc. Reports Second Quarter and Six Month 2019 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News